Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1998 1
2001 4
2002 8
2003 12
2004 8
2005 11
2006 10
2007 9
2008 11
2009 17
2010 19
2011 21
2012 18
2013 26
2014 30
2015 33
2016 24
2017 29
2018 27
2019 23
2020 38
2021 39
2022 31
2023 28
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

444 results

Results by year

Filters applied: . Clear all
Page 1
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Applied strategies of neuroplasticity.
Johnson BP, Cohen LG. Johnson BP, et al. Handb Clin Neurol. 2023;196:599-609. doi: 10.1016/B978-0-323-98817-9.00011-9. Handb Clin Neurol. 2023. PMID: 37620093 Review.
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rüb U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD. Elden AC, et al. Among authors: johnson bs. Nature. 2010 Aug 26;466(7310):1069-75. doi: 10.1038/nature09320. Nature. 2010. PMID: 20740007 Free PMC article.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31887225 Free PMC article. Clinical Trial.
Bridging generations.
Johnson BP. Johnson BP. Chem Rec. 2015 Feb;15(1):13-6. doi: 10.1002/tcr.201500003. Chem Rec. 2015. PMID: 25690989 No abstract available.
Engineering Neurobiological Systems: Addiction.
Johnson B. Johnson B. Psychiatr Clin North Am. 2018 Jun;41(2):331-339. doi: 10.1016/j.psc.2018.01.011. Psychiatr Clin North Am. 2018. PMID: 29739530 Free article. Review.
Crowdsourcing in Cognitive and Systems Neuroscience.
Johnson BP, Dayan E, Censor N, Cohen LG. Johnson BP, et al. Neuroscientist. 2022 Oct;28(5):425-437. doi: 10.1177/10738584211017018. Epub 2021 May 25. Neuroscientist. 2022. PMID: 34032146 Review.
Mosquito Age Grading and Vector-Control Programmes.
Johnson BJ, Hugo LE, Churcher TS, Ong OTW, Devine GJ. Johnson BJ, et al. Trends Parasitol. 2020 Jan;36(1):39-51. doi: 10.1016/j.pt.2019.10.011. Epub 2019 Dec 10. Trends Parasitol. 2020. PMID: 31836285 Review.
444 results